CSIMarket Company Name, Ticker, Industry, else..
 
Axsome Therapeutics Inc   (NASDAQ: AXSM)
 

Axsome Therapeutics Inc's Suppliers Performance

AXSM's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
AXSM Costs vs Sales of Suppliers Growth Axsome Therapeutics Inc recorded an increase in cost of sales by 0.86 % year on year, relative to one quarter ago cost of sales fell by -7.88 % in Q2.

• More on AXSM Suppliers



Axsome Therapeutics Inc recorded increase in cost of sales by 0.86 % year on year, compare to one quarter ago cost of sales fell by -7.88 % in Q2.

• More on AXSM Suppliers




Axsome Therapeutics Inc's Comment on Supply Chain


The company does not own or operate manufacturing facilities for clinical or commercial production of its drug candidates. It relies on existing suppliers for active pharmaceutical ingredients and finished products, which are considered capable of meeting commercial and clinical trial supply requirements. The company conducts periodic quality audits of these suppliers' facilities. Additionally, it may engage other contract manufacturing organizations (CMOs) in the future for clinical supplies and commercial manufacturing.

Axsome Therapeutics Inc's Comment on Supply Chain


The company does not own or operate manufacturing facilities for clinical or commercial production of its drug candidates. It relies on existing suppliers for active pharmaceutical ingredients and finished products, which are considered capable of meeting commercial and clinical trial supply requirements. The company conducts periodic quality audits of these suppliers' facilities. Additionally, it may engage other contract manufacturing organizations (CMOs) in the future for clinical supplies and commercial manufacturing.







AXSM's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Axsome Therapeutics Inc 10,840.12 776.57 -191.64 925
SUBTOTAL 0.00 0.00 0.00 -


Sources: Axsome Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Axsome Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.